Increased sensitivity of xeroderma pigmentosum skin fibroblasts to carcinogenic compounds.
D002273:Carcinogens; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D011083:Polycyclic Compounds / Q000009:adverse effects*; D012867:Skin / Q000187:drug effects*; D014983:Xeroderma Pigmentosum / Q000473:pathology*
D002273:Carcinogens; D011083:Polycyclic Compounds